Antithrombotic therapy for stroke in young adults.
Stroke in young adults is a markedly heterogeneous disease, and remains an understudied phenomenon. While advances are being made in our understanding of the pathophysiology of its underlying conditions, treatment concerns are controversial, and clinical trials are sorely lacking. This review presents an overview of some of the relevant management issues in hypercoagulable states, migraine, patent foramen ovale, vascular dissection and venous sinus thrombosis.
Payne
Jeremy R
JR
Department of Neurology, University of Arizona, USA.
Coull
Bruce
B
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000925:Anticoagulants / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000235:genetics; D020215:Carotid Artery, Internal, Dissection / Q000150:complications; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006344:Heart Septal Defects, Atrial / Q000150:complications; D006801:Humans; D008881:Migraine Disorders / Q000150:complications; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D055502:Secondary Prevention; D012851:Sinus Thrombosis, Intracranial / Q000150:complications; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D019851:Thrombophilia / Q000150:complications / Q000235:genetics; D020217:Vertebral Artery Dissection / Q000150:complications
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors